Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

Clinical trial NCT00600054 · COMPLETED

Trial details

NCT number: NCT00600054
Sponsor: YM BioSciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Diffuse Pontine Gliomas

Start date: 2007-10-01
Primary completion: 2010-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.